Edwards Lifesciences Corporation, the world leader in the science of heart valves, today announced at EuroPCR 2009 the results from its first post-market study of consecutively enrolled Edwards SAPIEN transcatheter aortic valve patients.
Cardio
Unique Proprietary Drug Eluting Balloon, with Paccocath® Technology, Readied For Global Market
MEDRAD Interventional™/Possis® announced that it has reached key milestones in bringing the Paccocath® Technology closer to market.
Medtronic’s Cardiac Ablation System Represents A Breakthrough Technology Platform
Medtronic, Inc. announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial. The study is evaluating the use of the Medtronic Ablation Frontiers Cardiac Ablation System, for the treatment of continuous atrial fibrillation.
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
Invatec, a comprehensive innovator of interventional products, today announced the availability of its newly CE marked coronary balloon, the IN.PACT™ Falcon paclitaxel-eluting PTCA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.
Boston Scientific Welcomes Launch of Syntax Score Website
Boston Scientific Corporation today welcomed the launch of a new website, www.syntaxscore.com, dedicated to the understanding and use of the SYNTAX Score™, a novel angiographic tool used to measure the complexity of coronary artery disease.
Terumo Heart, Inc. Reaches Clinical Milestone with the DuraHeart™ Left Ventricular Assist System
Terumo Heart Inc. today announced reaching a critical milestone in the worldwide expansion of its DuraHeart™ Left-Ventricular Assist System (LVAS) as the 100th patient was treated with the device.
Results of Medtronic-Supported implantable cardioverter-defibrillator (ICD) Clinical Trial
MVP® (Managed Ventricular Pacing), exclusive programming on Medtronic pacemakers was applied in the MVP Trial of implantable cardioverter-defibrillator patients.
Use Of The MitraClip® Therapy Continues To Expand In Europe, First 100 Patients Treated
Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip® system in Europe.
Enrollment Complete For Medtronic Clinical Trial Evaluating Radiofrequency Ablation Tools
Medtronic, Inc. today announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial.
Invatec Receives CE Mark Approval for the IN.PACT Admiral Drug Eluting Balloon
Invatec, a comprehensive innovator of interventional products, today announced the receipt of the CE Mark and the European launch of its IN.PACT™ Admiral paclitaxel-eluting PTA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.
Medtronic Demonstrates Positive Results On First Pacemaker Designed For Use With MRI
New data announced at Heart Rhythm 2009, the annual congress of the Heart Rhythm Society, demonstrate that patients implanted with the investigational EnRhythm MRI™ SureScan™ pacing system experienced no complications related to the use of magnetic resonance imaging.
Medtronic Device Registry First To Show How Implantable Heart Devices Work In Real-World
The first results from the Medtronic Inc. OMNI Study were released at Heart Rhythm 2009, revealing that one out of six patients received potentially life-saving medical therapy within the two years following their implant.
St. Jude Medical Announces European Approval of Accent RF and Anthem RF Pacemakers
St. Jude Medical, Inc. today announced European CE Mark approval of its Accent™ RF and Anthem™ RF CRT-P Pacemakers, equipped with wireless technology.
Boston Scientific to Donate Cardiac Rhythm Management Devices to Needy Patients
Boston Scientific Corporation today announced that it has agreed to donate Cardiac Rhythm Management devices to Heartbeat International, to implant in needy patients in countries outside the US.
Medtronic Announces U.S. Trial Of Unique Therapy For Closure Of The Left Atrial Appendage
Medtronic, Inc. announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device as part of a U.S. clinical trial.
St. Jude Medical Announces European Approval of Its Newest and Most Efficient Heart Failure Devices
St. Jude Medical, Inc. today announced European CE Mark approval of its Promote Accel™ implantable cardiac resynchronization therapy defibrillator (CRT-D).